Waters (WAT) Competitors $287.39 -9.53 (-3.21%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$287.32 -0.07 (-0.02%) As of 07/18/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock WAT vs. BRKR, TECH, A, DHR, IQV, MTD, RVTY, TMO, ILMN, and CRLShould you be buying Waters stock or one of its competitors? The main competitors of Waters include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Illumina (ILMN), and Charles River Laboratories International (CRL). Waters vs. Its Competitors Bruker Bio-Techne Agilent Technologies Danaher IQVIA Mettler-Toledo International Revvity Thermo Fisher Scientific Illumina Charles River Laboratories International Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both life sciences tools & services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations. Do insiders and institutionals hold more shares of WAT or BRKR? 94.0% of Waters shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.8% of Waters shares are owned by insiders. Comparatively, 27.3% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, WAT or BRKR? Waters has higher earnings, but lower revenue than Bruker. Waters is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWaters$2.96B5.78$637.83M$11.0226.08Bruker$3.37B1.83$113.10M$0.5277.98 Is WAT or BRKR more profitable? Waters has a net margin of 22.02% compared to Bruker's net margin of 2.31%. Waters' return on equity of 41.70% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets Waters22.02% 41.70% 15.67% Bruker 2.31%19.47%5.95% Does the media favor WAT or BRKR? In the previous week, Waters had 61 more articles in the media than Bruker. MarketBeat recorded 74 mentions for Waters and 13 mentions for Bruker. Bruker's average media sentiment score of 0.71 beat Waters' score of 0.21 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 19 Very Positive mention(s) 11 Positive mention(s) 26 Neutral mention(s) 5 Negative mention(s) 8 Very Negative mention(s) Neutral Bruker 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate WAT or BRKR? Waters currently has a consensus price target of $381.94, suggesting a potential upside of 32.90%. Bruker has a consensus price target of $52.89, suggesting a potential upside of 30.43%. Given Waters' stronger consensus rating and higher probable upside, equities analysts clearly believe Waters is more favorable than Bruker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waters 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.56Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more volatility and risk, WAT or BRKR? Waters has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. SummaryWaters beats Bruker on 12 of the 17 factors compared between the two stocks. Get Waters News Delivered to You Automatically Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WAT vs. The Competition Export to ExcelMetricWatersMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$17.11B$6.65B$5.53B$20.82BDividend YieldN/A1.33%4.00%3.65%P/E Ratio26.0825.6528.2527.57Price / Sales5.7862.29412.5859.32Price / Cash19.0120.4724.9917.94Price / Book9.334.618.094.66Net Income$637.83M$176.14M$3.25B$995.01M7 Day Performance-18.57%0.40%1.63%-0.30%1 Month Performance-16.09%2.96%7.62%4.91%1 Year Performance-5.06%3.10%32.74%11.21% Waters Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WATWaters4.9046 of 5 stars$287.39-3.2%$381.94+32.9%-5.1%$17.11B$2.96B26.087,600Trending NewsAnalyst DowngradeAnalyst RevisionBRKRBruker4.9854 of 5 stars$43.21-1.3%$52.89+22.4%-34.5%$6.55B$3.37B83.1011,396News CoverageAnalyst RevisionTECHBio-Techne4.86 of 5 stars$52.62-2.8%$70.00+33.0%-31.1%$8.25B$1.16B64.173,100Analyst RevisionAAgilent Technologies4.848 of 5 stars$120.10-2.6%$139.77+16.4%-13.5%$34.12B$6.51B29.6517,900Positive NewsDHRDanaher4.9654 of 5 stars$197.69-3.5%$248.43+25.7%-22.0%$141.48B$23.88B38.3963,000Positive NewsUpcoming EarningsAnalyst ForecastIQVIQVIA4.9001 of 5 stars$160.06-1.7%$222.45+39.0%-28.4%$27.69B$15.41B21.8188,000Positive NewsUpcoming EarningsMTDMettler-Toledo International4.0465 of 5 stars$1,195.06-2.4%$1,280.90+7.2%-10.9%$24.84B$3.83B29.8017,300Positive NewsRVTYRevvity3.8939 of 5 stars$98.51-2.9%$123.07+24.9%-13.8%$11.61B$2.77B41.9211,000News CoverageAnalyst DowngradeAnalyst RevisionTMOThermo Fisher Scientific4.9885 of 5 stars$425.44-2.2%$600.30+41.1%-22.3%$160.60B$42.90B24.95125,000Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionILMNIllumina4.887 of 5 stars$98.53-0.7%$125.11+27.0%-16.0%$15.60B$4.37B-16.239,030Analyst RevisionCRLCharles River Laboratories International4.7579 of 5 stars$158.09-0.8%$174.54+10.4%-29.2%$7.77B$4.05B-243.2120,100Positive News Related Companies and Tools Related Companies BRKR Competitors TECH Competitors A Competitors DHR Competitors IQV Competitors MTD Competitors RVTY Competitors TMO Competitors ILMN Competitors CRL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:WAT) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waters Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Waters With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.